Theriva Biologics, Inc. Accrued Liabilities, Current
Theriva Biologics, Inc. (TOVX) had Accrued Liabilities, Current of $6.42 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Accrued Liabilities, Current $6.42M.
- 2026-03-31: Accrued Liabilities, Current $6.22M.
- 2025-12-31: Accrued Liabilities, Current $6.28M.
- 2025-09-30: Accrued Liabilities, Current $7.68M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.42M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $6.22M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $6.28M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $7.68M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $9.02M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.37M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $3.75M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.49M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.33M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.00M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $5.59M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.83M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.50M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $1.41M 10-K · filed 2023-03-30 | |
| 2022-06-30 | $1.99M 10-K · filed 2023-03-30 | |
| 2022-03-31 | $1.53M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.93M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.01M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $794.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $854.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $925.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $988.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.21M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.78M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $2.32M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $1.54M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.63M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $919.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | $1.49M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.00M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.06M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.53M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $2.07M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $1.75M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $2.13M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.63M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $1.49M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $1.84M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $946.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $297.00K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $244.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.61M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $2.65M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.30M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $111.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $153.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $882.00K 10-K · filed 2015-03-16 | $885.00K 10-K · filed 2014-03-31 |
| 2013-06-30 | $16.00K 10-Q · filed 2013-08-14 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 | |
| 2012-09-30 | $27.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $117.00K 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $127.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $29.00K 10-K · filed 2013-04-16 | |
| 2011-09-30 | $41.01K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $22.72K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $210.00K 10-K/A · filed 2012-05-11 | $210.03K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |